Improving patient compliance in therapy requires developing minimally invasive and non-invasive drug delivery systems that enhance drug transport while minimizing procedural risks and recovery time. Our efforts focus on biomaterial-based formulations, nanocarriers, and peptide-based delivery systems that facilitate the precise transport of therapeutic agents through intranasal, transdermal, and oral routes. These advanced systems leverage cutting-edge materials science and molecular engineering to improve bioavailability, enhance drug stability, and enable controlled or sustained release, thereby ensuring optimal therapeutic outcomes.

By integrating biomaterials, nanotechnology, and peptide engineering, we aim to advance drug delivery strategies, offering safer, more efficient, and patient-friendly alternatives to traditional administration routes. Our goal is to develop next-generation therapeutics that not only improve drug efficacy but also enhance the overall patient experience, ultimately leading to better treatment.